Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2022-08-09 AGM Information
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
110年年報及股東會資料 — 2022_1734_20220621F05.pdf
AGM Information Classification · 95% confidence The document is a detailed record of the Annual General Meeting (AGM) of 杏輝藥品工業股份有限公司 for the year 111 (2022). It includes attendance details, chairman's speech, reports on the previous year's business and financial results, approval of financial statements, loss compensation, capital surplus cash distribution, amendments to articles of incorporation, and other procedural matters. It also contains attachments such as the 110th year business report, audit committee review report, and financial statements. The content is typical of AGM minutes and materials presented and approved during the meeting, including voting results on various proposals. The document is lengthy (15,000 characters) and contains substantive content rather than just an announcement or a brief summary. Therefore, it fits the category of AGM Information (AGM-R).
2022-08-09 Chinese
110年年報及股東會資料 — 2022_1734_20220621F17.pdf
Major Shareholding Notification Classification · 95% confidence The document contains a table listing the top ten shareholders and their relationships, including shareholding percentages and familial or related party connections. It is a detailed disclosure of major shareholders and their interrelations, which aligns with notifications about significant share ownership levels. There is no indication of financial statements, management commentary, or meeting materials. The document length is short and focused solely on shareholding information, fitting the definition of a Major Shareholding Notification.
2022-08-09 Chinese
110年年報及股東會資料 — 2021_1734_20220621F04.pdf
Regulatory Filings
2022-08-09 Chinese
110年年報及股東會資料 — 2022_1734_20220621F13.pdf
AGM Information Classification · 95% confidence The document is titled as reference materials for the Annual General Meeting (AGM) of 杏輝藥品工業股份有限公司 for the year 民國111 (which corresponds to 2022-2023). It contains agenda items for approval and discussion, including approval of the annual business report and financial statements, loss compensation, capital surplus cash distribution, and amendments to articles and procedures. The document references attachments and detailed materials in a meeting handbook, indicating it is a presentation or reference material for the AGM rather than the full annual report itself. The length is only 1335 characters, which is quite short and consistent with meeting materials rather than a full report. Therefore, this document fits best as AGM Information (AGM-R).
2022-08-09 Chinese
110年年報及股東會資料 — 2022_1734_20220621FE1.pdf
AGM Information Classification · 95% confidence The document is a notice for the 2022 Annual Shareholders' Meeting of Sinphar Pharmaceutical Co., Ltd. It includes the meeting agenda, which covers reports, items for approval, and discussion topics typically presented at an AGM. The document does not contain the actual reports or financial statements but rather announces the meeting and its agenda. The document length is short (1830 characters), and it serves as a notification rather than the full report or minutes. Therefore, it fits the category of AGM Information (AGM-R).
2022-08-09 Chinese
110年年報及股東會資料 — 2022_1734_20220621F02.pdf
Regulatory Filings
2022-08-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.